Abivax SA
Stock Details
Is it expensive?
Market Cap
7.00B
Trailing P/E Ratio
-18.19
Forward P/E Ratio
-26.93
PEG Ratio
0.69
6.20B
-24.41
Price-to-Sales (TTM)
1.36K
15.49
5.42
Is it profitable?
4.92M
Net Profit Margin (TTM)
0.00%
Gross Profit Margin
0.00%
Diluted EPS (TTM)
-4.61
-157.07%
Is it growing?
35.20%
0.00%
Is it risky?
-0.20
7.96
34.21M
8.25
Who owns it?
50.80%
4.54%
0.00%
79.29M
58.23M
Does it pay?
0.00%
0.00%
--
--
How much cash?
491.55M
-178.37M
-114.47M
6.20
- Price (EOD)
- 87.85
- Percent Change
- +3.90 (4.65%)
- Previous Close
- 83.95
- Open
- 86.50
- Low
- 85.65
- High
- 93.35
52-Week Range Position (52WRP)
Above Average
Above Average
within its 1-year price range
€87.85
From 52W Low
+1615.82%
From 52W High
-33.45%
Today
+4.65%
1Y Change
+1153.21%
6M
€94.30
3M
€99.10
1M
€110.20
Today
€87.85
From 52W Low
+1615.82%
From 52W High
-33.45%
Today
+4.65%
1Y Change
+1153.21%
6M
€94.30
3M
€99.10
1M
€110.20
Today
€87.85
Above Average
within its 1-year price range
€87.85
Multi-Timeframe Analysis (MTA)
Downtrend
Most timeframes point down. One conflicting period introduces some uncertainty, but the overall direction is negative. Weaker than a Strong Downtrend, but still a bearish signal. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-20.3%
3M
-11.4%
6M
-6.8%
1Y
+1153.2%
Rate of Change (ROC)
Decelerating
Price has reversed, now falling vs its usual uptrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Average
Volume is in line with the 90-day average. No unusual activity detected. Price moves on average volume carry less confirmation. As reflected in the Relative Volume (RVOL) below.
- Name
- Abivax SA
- Founded
- 2013
- CEO
- Marc M. P. de Garidel
- Employees
- 80
- Fiscal Year End
- Dec 31, 2025
- Address
7-11 Boulevard Haussmann
Paris
MI
75009
France
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.abivax.com
Indicators
Operating Cash Flow
-178.37M
Net Income
-332.20M
Mixed Signal
0.54
Cash flow is meaningfully below reported profit. Some gap is normal, but a persistent gap warrants questioning of the accounting.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Related Heatmaps
SBF 120Index SBF 120 - PX4 |
Indicators
Operating Cash Flow
-178.37M
Net Income
-332.20M
Mixed Signal
0.54
Cash flow is meaningfully below reported profit. Some gap is normal, but a persistent gap warrants questioning of the accounting.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Market Cap
7.00B
Trailing P/E Ratio
-18.19
Forward P/E Ratio
-26.93
PEG Ratio
0.69
6.20B
-24.41
Price-to-Sales (TTM)
1.36K
15.49
5.42
Is it profitable?
4.92M
Net Profit Margin (TTM)
0.00%
Gross Profit Margin
0.00%
Diluted EPS (TTM)
-4.61
-157.07%
Is it growing?
35.20%
0.00%
Is it risky?
-0.20
7.96
34.21M
8.25
Who owns it?
50.80%
4.54%
0.00%
79.29M
58.23M
Does it pay?
0.00%
0.00%
--
--
How much cash?
491.55M
-178.37M
-114.47M
6.20
- Price (EOD)
- 87.85
- Percent Change
- +3.90 (4.65%)
- Previous Close
- 83.95
- Open
- 86.50
- Low
- 85.65
- High
- 93.35
52-Week Range Position (52WRP)
Above Average
Above Average
within its 1-year price range
€87.85
From 52W Low
+1615.82%
From 52W High
-33.45%
Today
+4.65%
1Y Change
+1153.21%
6M
€94.30
3M
€99.10
1M
€110.20
Today
€87.85
From 52W Low
+1615.82%
From 52W High
-33.45%
Today
+4.65%
1Y Change
+1153.21%
6M
€94.30
3M
€99.10
1M
€110.20
Today
€87.85
Above Average
within its 1-year price range
€87.85
Multi-Timeframe Analysis (MTA)
Downtrend
Most timeframes point down. One conflicting period introduces some uncertainty, but the overall direction is negative. Weaker than a Strong Downtrend, but still a bearish signal. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-20.3%
3M
-11.4%
6M
-6.8%
1Y
+1153.2%
Rate of Change (ROC)
Decelerating
Price has reversed, now falling vs its usual uptrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Average
Volume is in line with the 90-day average. No unusual activity detected. Price moves on average volume carry less confirmation. As reflected in the Relative Volume (RVOL) below.
- Name
- Abivax SA
- Founded
- 2013
- CEO
- Marc M. P. de Garidel
- Employees
- 80
- Fiscal Year End
- Dec 31, 2025
- Address
7-11 Boulevard Haussmann
Paris
MI
75009
France
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.abivax.com
Related Heatmaps
SBF 120Index SBF 120 - PX4 |